Skip to main
USPH

USPH Stock Forecast & Price Target

USPH Analyst Ratings

Based on 4 analyst ratings
Buy
Strong Buy 25%
Buy 75%
Hold 0%
Sell 0%
Strong Sell 0%

Bulls say

US Physical Therapy is focused on expanding their operations through both M&A activities and de novo clinic openings. Their strong financials, demonstrated by a consistent increase in revenue and profitability, support their growth strategy and their relationships with various payment sources provide a stable revenue stream. Their industrial injury prevention segment presents significant opportunities for organic growth, and their partnerships with hospitals and healthcare systems have the potential to be a key driver of future growth. Overall, US Physical Therapy has a strong business model and favorable industry dynamics, leading to a positive outlook for their stock.

Bears say

US Physical Therapy is facing challenges with its hospital partnership strategy, as it has yet to see a significant impact on its financials despite efforts to ramp up volumes. Additionally, the company's sustainability relies heavily on its partnerships with hospitals and M&A opportunities, making it vulnerable to changes outside of its control. Lastly, while the company's recent financial results were positive, its growth is not entirely organic, as it includes contributions from recent acquisitions.

USPH has been analyzed by 4 analysts, with a consensus rating of Buy. 25% of analysts recommend a Strong Buy, 75% recommend Buy, 0% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of U.S. Physical Therapy and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About U.S. Physical Therapy (USPH) Forecast

Analysts have given USPH a Buy based on their latest research and market trends.

According to 4 analysts, USPH has a Buy consensus rating as of Jun 29, 2026. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $97.50, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $97.50, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

U.S. Physical Therapy (USPH)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.